TrialVaccine2026

Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination.

Sharon E Frey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.